Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 24, 2024NutrientsOpen Access

Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency

View Full Paper
Ask AI
Bookmark
Share

Authors

DCDavide CesaranoSBSilvio BorrelliGCGiorgia Campilongo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cesarano et al. (2024) studied this question.

synapsesocial.com/papers/68e6dc18b6db6435876580fehttps://doi.org/10.3390/nu16091255
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1#2264 Efficacy and safety of oral iron supplementation with liposomal iron in non-dialysis chronic kidney disease patients with iron deficiency2024
  2. 2Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-dialysis Chronic Kidney Disease Patients: A Non-inferiority Study2024 · 1 citations
  3. 3Oral liposomal iron vs. oral iron polymaltose in children with chronic kidney disease iron deficiency anemia: a cross-over study2026 · 1 citations
  4. 4Efficacy of liposomal bivalent stabilized iron sulfate in improving iron deficiency and quality of life in patients with chronic heart failure: lower costs for better therapy?2025
  5. 5Randomized Controlled Trial Comparing Lactoferrin Plus Iron to Iron Alone for Iron Deficiency Anemia in CKD2026